News & Events

20 Sep 2021
Last week’s round -up;
13 -17 September 2021

New EMA Product-Specific Bioequivalence Guidance
The EMA has adopted the following new product-specific bioequivalence guidance, which come into effect on the 1st November 2021:
· Acenocoumarol, tablet, 1 mg and 4 mg
· Lapatinib film-coated tablet 250 …

Search Real Regulatory